Denville-based Healthcare Corporation of America announced today the appointment of Natasha Giordano as chief executive officer.
According to the announcement, Giordano, whose appointment is effective Friday, succeeds Gary Sekulski. Giordano was also elected a director of the company's board. In addition, the company announced the appointment of Yaron Eitan as chairman, also succeeding Sekulski, who will continue to assist the Company with its business development activities. Ms. Giordano brings over 20 years of experience in various leadership positions in the healthcare industry. Giordano served as chief executive officer, president and director of Xanodyne Pharmaceuticals Inc., a branded specialty pharmaceutical company with development and commercial capabilities focused on pain management.